BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10627471)

  • 1. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.
    Chiarle R; Budel LM; Skolnik J; Frizzera G; Chilosi M; Corato A; Pizzolo G; Magidson J; Montagnoli A; Pagano M; Maes B; De Wolf-Peeters C; Inghirami G
    Blood; 2000 Jan; 95(2):619-26. PubMed ID: 10627471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma.
    Izban KF; Alkan S; Singleton TP; Hsi ED
    Arch Pathol Lab Med; 2000 Oct; 124(10):1457-62. PubMed ID: 11035575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.
    Quintanilla-Martinez L; Thieblemont C; Fend F; Kumar S; Pinyol M; Campo E; Jaffe ES; Raffeld M
    Am J Pathol; 1998 Jul; 153(1):175-82. PubMed ID: 9665478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.
    Møller MB; Kania PW; Ino Y; Gerdes AM; Nielsen O; Louis DN; Skjødt K; Pedersen NT
    Leukemia; 2000 May; 14(5):898-904. PubMed ID: 10803523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F-1 overexpression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I.
    von Harsdorf R; Hauck L; Mehrhof F; Wegenka U; Cardoso MC; Dietz R
    Circ Res; 1999 Jul; 85(2):128-36. PubMed ID: 10417394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.
    Loda M; Cukor B; Tam SW; Lavin P; Fiorentino M; Draetta GF; Jessup JM; Pagano M
    Nat Med; 1997 Feb; 3(2):231-4. PubMed ID: 9018245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
    Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67.
    Wu Y; Luo H; Kanaan N; Wu J
    J Cell Biochem; 2000 Jan; 76(4):596-604. PubMed ID: 10653979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27(Kip1) is an inducer of intestinal epithelial cell differentiation.
    Quaroni A; Tian JQ; Seth P; Ap Rhys C
    Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1045-57. PubMed ID: 11003585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis.
    Quintanilla-Martinez L; Davies-Hill T; Fend F; Calzada-Wack J; Sorbara L; Campo E; Jaffe ES; Raffeld M
    Blood; 2003 Apr; 101(8):3181-7. PubMed ID: 12515730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma.
    Guidoboni M; Zancai P; Cariati R; Rizzo S; Dal Col J; Pavan A; Gloghini A; Spina M; Cuneo A; Pomponi F; Bononi A; Doglioni C; Maestro R; Carbone A; Boiocchi M; Dolcetti R
    Cancer Res; 2005 Jan; 65(2):587-95. PubMed ID: 15695403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
    Halevy O; Novitch BG; Spicer DB; Skapek SX; Rhee J; Hannon GJ; Beach D; Lassar AB
    Science; 1995 Feb; 267(5200):1018-21. PubMed ID: 7863327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo.
    Vogt N; Abramov D; Koch K; Masqué-Soler N; Szczepanowski M; Klapper W
    Leuk Lymphoma; 2015 Jul; 56(7):2134-40. PubMed ID: 25315075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.